Clinical Response to Linaclotide at Week 4 Predicts Sustained Response in Irritable Bowel Syndrome With Constipation and Improvements in Digestive and Extra-Digestive Symptoms

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756284819857358

Related search